We used Illumina Human HT-12 v4 arrays to compare RNA expression of middle temporal gyrus (MTG; BA21) in Alzheimer’s disease (AD = 97) and non-demented controls (ND = 98). A total of 938 transcripts were highly differentially expressed (adj p < 0.01; log2 FC ≥ |0.500|, with 411 overexpressed and 527 underexpressed in AD. Our results correlated with expression profiling in neurons from AD and ND obtained by laser capture microscopy in MTG from an independent dataset (log2 FC correlation: r = 0.504; p = 2.2e-16). Additionally, selected effects were validated by qPCR. ANOVA analysis yielded no difference between genders in response to AD, but some gender specific genes were detected (e.g., IL8 and AGRN in males, and HSPH1 and GRM1 in females). Several transcripts were associated with Braak staging (e.g., AEBP1 and DNALI1), antemortem MMSE (e.g., AEBP1 and GFAP), and tangle density (e.g., RNU1G2, and DNALI1). At the pathway level, we detected enrichment of synaptic vesicle processes and GABAergic transmission genes. Finally, applying the Weighted Correlation Network Analysis, we identified four expression modules enriched for neuronal and synaptic genes, mitochondria-associated membrane, chemical stimulus and olfactory receptor and non-coding RNA metabolism genes. Our results represent an extensive description of MTG mRNA profiling in a large sample of AD and ND. These data provide a list of genes associated with AD, and correlated to neurofibrillary tangles density. In addition, these data emphasize the importance of mitochondrial membranes and transcripts related to olfactory receptors in AD.
MendezMF, LeeAS, JoshiA, ShapiraJS (2012) Nonamnestic presentations of early-onset Alzheimer’s disease. Am J Alzheimers Dis Other Demen27, 413–420.
2.
FrisoniGB, PievaniM, TestaC, SabattoliF, BrescianiL, BonettiM, BeltramelloA, HayashiKM, TogaAW, ThompsonPM (2007) The topography of grey matter involvement in early and late onset Alzheimer’s disease. Brain130, 720–730.
3.
Alzheimer’s Association (2015) 2015 Alzheimer’s disease facts and figures. Alzheimers Dement11, 332–384.
4.
PrinceM, BryceR, AlbaneseE, WimoA, RibeiroW, FerriCP (2015) The global prevalence of dementia: A systematic review and metaanalysis. Alzheimers Dement9, 63–75.e2.
5.
QuerfurthHW, LaFerlaFM (2010) Alzheimer’s disease: Mechanism of disease. N Engl J Med362, 329–344.
6.
ConvitA, De AsisJ, De LeonMJ, TarshishCY, De SantiS, RusinekH (2000) Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer’s disease. Neurobiol Aging21, 19–26.
7.
CabezaR, NybergL (2000) Neural bases of learning and memory: Functional neuroimaging evidence. Curr Opin Neurol13, 415–421.
8.
FaustM (2012), The Handbook of the Neuropsychology of Language.
9.
GradyMS, CharlestonJS, MarisD, WitgenBM, LifshitzJ (2003) Neuronal and glial cell number in the hippocampus after experimental traumatic brain injury: Analysis by stereological estimation. J Neurotrauma20, 929–941.
10.
ChowN, CoxC, CallahanLM, WeimerJM, GuoL, ColemanPD (1998) Expression profiles of multiple genes in single neurons of Alzheimer’s disease. Proc Natl Acad Sci U S A95, 9620–9625.
11.
MastroeniD, KhdourOM, DelvauxE, NolzJ, OlsenG, BerchtoldN, CotmanC, HechtSM, ColemanPD (2017) Nuclear but not mitochondrial-encoded oxidative phosphorylation genes are altered in aging, mild cognitive impairment, and Alzheimer’s disease. Alzheimers Dement13, 510–519.
12.
HokamaM, OkaS, LeonJ, NinomiyaT, HondaH, SasakiK, IwakiT, OharaT, SasakiT, LaFerlaFM, KiyoharaY, NakabeppuY (2014) Altered expression of diabetes-related genes in Alzheimer’s disease brains: The Hisayama study. Cereb Cortex24, 2476–2488.
13.
BlalockEM, BuechelHM, PopovicJ, GeddesJW, LandfieldPW (2011) Microarray analyses of laser-captured hippocampus reveal distinct gray and white matter signatures associated with incipient Alzheimer’s disease. J Chem Neuroanat42, 118–126.
14.
BerchtoldNC, ColemanPD, CribbsDH, RogersJ, GillenDL, CotmanCW (2013) Synaptic genes are extensively downregulated across multiple brain regions in normal human aging and Alzheimer’s disease. Neurobiol Aging34, 1653–1661.
15.
LiangWS, DunckleyT, BeachTG, GroverA, MastroeniD, RamseyK, CaselliRJ, KukullWA, McKeelD, MorrisJC, HuletteCM, SchmechelD, ReimanEM, RogersJ, StephanDA (2008) Altered neuronal gene expression in brain regions differentially affected by Alzheimer’s disease: A reference data set. Physiol Genomics33, 240–256.
16.
LiangWS, DunckleyT, BeachTG, GroverA, MastroeniD, WalkerDG, CaselliRJ, KukullWA, McKeelD, MorrisJC, HuletteC, SchmechelD, AlexanderGE, ReimanEM, RogersJ, StephanDA (2007) Gene expression profiles in anatomically and functionally distinct regions of the normal aged human brain. Physiol Genomics28, 311–322.
17.
BeachTG, AdlerCH, SueLI, SerranoG, ShillHA, WalkerDG, LueL, RoherAE, DuggerBN, MaaroufC, BirdsillAC, IntorciaA, Saxon-LabelleM, PullenJ, ScrogginsA, FilonJ, ScottS, HoffmanB, GarciaA, CavinessJN, HentzJG, Driver-DunckleyE, JacobsonSA, DavisKJ, BeldenCM, LongKE, Malek-AhmadiM, PowellJJ, GaleLD, NicholsonLR, CaselliRJ, WoodruffBK, RapscakSZ, AhernGL, ShiJ, BurkeAD, ReimanEM, SabbaghMN (2015) Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program. Neuropathology35, 354–389.
18.
DuP, KibbeWA, LinSM (2008) lumi: A pipeline for processing Illumina microarray. Bioinformatics24, 1547–1548.
BenjaminiY, HochbergY (1995) Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc B57, 289–300.
24.
ChenJ, BardesEE, AronowBJ, JeggaAG (2009) ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res37(Web Server issue), W305–W311.
25.
KanehisaM, GotoS (2000) KEGG: Kyoto Encyclopaedia of Genes and Genomes. Nucl Acids Res28, 27–30.
26.
MiH, DongQ, MuruganujanA, GaudetP, LewisS, ThomasPD (2009) PANTHER version 7: Improved phylogenetic trees, orthologs and collaboration with the Gene Ontology Consortium. Nucleic Acids Res38(Database issue), D204–D210.
27.
MiH, PoudelS, MuruganujanA, CasagrandeJT, ThomasPD (2016) PANTHER version 10: Expanded protein families and functions, and analysis tools. Nucleic Acids Res44, D336–D342.
28.
VenablesWN, RipleyBD (2002), Modern applied statistics with S.
Springer-VerlagNew York.
29.
R CoreTeam (2016) R Development Core Team. R A Lang Environ Stat Comput55, 275–286.
30.
IrizarryRA, HobbsB, CollinF, Beazer-BarclayYD, AntonellisKJ, ScherfU, SpeedTP (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics4, 249–264.
31.
ZhangB, HorvathS (2005) A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol4, Article17.
32.
LeeHK, HsuAK, SajdakJ, QinJ, PavlidisP (2004) Coexpression analysis of human genes across many microarray data sets. Genome Res14, 1085–1094.
33.
LangfelderP, HorvathS (2008) WGCNA: An R package for weighted correlation network analysis. BMC Bioinformatics9, 559.
34.
LangfelderP, HorvathS (2007) Eigengene networks for studying the relationships between co-expression modules. BMC Syst Biol1, 54.
35.
AllenM, CarrasquilloMM, FunkC, HeavnerBD, ZouF, YounkinCS, BurgessJD, ChaiHS, CrookJ, EddyJA, LiH, LogsdonB, PetersMA, DangKK, WangX, SerieD, WangC, NguyenT, LincolnS, MalphrusK, BisceglioG, LiM, GoldeTE, MangraviteLM, AsmannY, PriceND, PetersenRC, Graff-RadfordNR, DicksonDW, YounkinSG, Ertekin-TanerN (2016) Human whole genome genotype and transcriptome data for Alzheimer’s and other neurodegenerative diseases. Sci Data3, 160089.
36.
LangfelderP, LuoR, OldhamMC, HorvathS (2011) Is my network module preserved and reproducible?PLoS Comput Biol7, e1001057.
37.
MancarciBO, TokerL, TripathySJ, LiB, RoccoB, SibilleE, PavlidisP (2017) Cross-laboratory analysis of brain cell type transcriptomes with applications to interpretation of bulk tissue data. eNeuro4, ENEURO.0212-17.2017.
38.
TerryRD, MasliahE, SalmonDP, ButtersN, DeTeresaR, HillR, HansenLA, KatzmanR (1991) Physical basis of cognitive alterations in alzheimer’s disease: Synapse loss is the major correlate of cognitive impairment. Ann Neurol30, 572–580.
39.
GautamV, D’AvanzoC, BerezovskaO, TanziRE, KovacsDM (2015) Synaptotagmins interact with APP and promote Aβ generation. Mol Neurodegener10, 1–15.
40.
KuzuyaA, ZoltowskaKM, PostKL, ArimonM, LiX, SvirskyS, MaesakoM, MuzikanskyA, GautamV, KovacsD, HymanBT, BerezovskaO (2016) Identification of the novel activity-driven interaction between synaptotagmin 1 and presenilin 1 links calcium, synapse, and amyloid beta. BMC Biol14, 25.
41.
SaetreP, JazinE, EmilssonL (2011) Age-related changes in gene expression are accelerated in Alzheimer’s disease. Synapse65, 971–974.
42.
EmilssonL, SaetreP, JazinE (2006) Alzheimer’s disease: MRNA expression profiles of multiple patients show alterations of genes involved with calcium signaling. Neurobiol Dis21, 618–625.
43.
BlalockEM, GeddesJW, ChenKC, PorterNM, MarkesberyWR, LandfieldPW (2004) Incipient Alzheimer’s disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc Natl Acad Sci U S A101, 2173–2178.
44.
MumaNA, MariyappaR, WilliamsK, LeeJM (2003) Differences in regional and subcellular localization of Gq/11 and RGS4 protein levels in Alzheimer’s disease: Correlation with muscarinic M1 receptor binding parameters. Synapse47, 58–65.
45.
GerberKJ, SquiresKE, HeplerJR (2016) Roles for regulator of G protein signaling proteins in synaptic signaling and plasticity. Mol Pharmacol89, 273–286.
46.
JungS, SonH, LeeDH, RohGS, KangSS, ChoGJ, ChoiWS, KimHJ (2016) Decreased levels of RGS4 in the paraventricular nucleus facilitate GABAergic inhibition during the acute stress response. Biochem Biophys Res Commun472, 276–280.
47.
OkazakiT, WangH, MasliahE, CaoM, JohnsonSA, SundsmoM, SaitohT, MoriN (1995) SCG 10, a neuron-specific growth-associated protein in Alzheimer’s disease. Neurobiol Aging16, 883–894.
48.
FeniliD, WengYQ, AubertI, NitzM, McLaurinJ (2011) Sodium/myo-inositol transporters: Substrate transport requirements and regional brain expression in the TgCRND8 mouse model of amyloid pathology. PLoS One6, e24032.
SumiokaA, ImotoS, MartinsRN, KirinoY, SuzukiT (2003) XB51 isoforms mediate Alzheimer’s beta-amyloid peptide production by X11L (X11-like protein)-dependent and -independent mechanisms. Biochem J374, 261–268.
51.
ParkJY, JangH, CurryTE, SakamotoA, JoM (2013) Prostate androgen-regulated mucin-like protein 1: A novel regulator of progesterone metabolism. Mol Endocrinol27, 1871–1886.
52.
JavittNB (2013) Alzheimer’s disease: Neuroprogesterone, epoxycholesterol, and abc transporters as determinants of neurodesmosterol tissue levels and its role in amyloid protein processing. J Alzheimers Dis35, 441–450.
SuttonRB, FasshauerD, JahnR, BrungerAT (1998) Crystal structure of a SNARE complex involved in synaptic exocytosis at 2.4A resolution. Nature395, 347–353.
55.
YaoPJ, ZhuM, PyunEI, BrooksAI, TherianosS, MeyersVE, ColemanPD (2003) Defects in expression of genes related to synaptic vesicle trafficking in frontal cortex of Alzheimer’s disease. Neurobiol Dis12, 97–109.
56.
BaiX, EddenRAE, GaoF, WangG, WuL, ZhaoB, WangM, ChanQ, ChenW, BarkerPB (2015) Decreased gamma-aminobutyric acid levels in the parietal region of patients with Alzheimer’s disease. J Magn Reson Imaging41, 1326–1331.
57.
GovindpaniK, GuzmánBCF, VinnakotaC, WaldvogelHJ, FaullRL, KwakowskyA (2017) Towards a better understanding of GABAergic remodeling in Alzheimer’s disease. Int J Mol Sci18, E1813.
AlbequerqueMS, MaharI, DavoliMA, ChabotJG, MechawarN, QuirionR, KranticS (2015) Regional and sub-regional differences in hippocampal GABAergic neuronal vulnerability in the TgCRND8 mouse model of Alzheimer’s disease. Front Aging Neurosci7, 30.
60.
LimonA, Reyes-RuizJM, MilediR (2012) Loss of functional GABAA receptors in the Alzheimer diseased brain. Proc Natl Acad Sci U S A109, 10071–10076.
61.
MclarnonJG (2016) Chemokine interleukin-8 (IL-8) in Alzheimer’s and other neurodegenerative diseases. J Alzheimers Dis Park6, 273.
62.
McLarnonJG (2012) Microglial chemotactic signaling factors in Alzheimer’s disease. Am J Neurodegener Dis1, 199–204.
63.
WalkerDG, LueLF, BeachTG (2001) Gene expression profiling of amyloid beta peptide-stimulated human post-mortem brain microglia. Neurobiol Aging22, 957–966.
64.
LueLF, RydelR, BrighamEF, YangLB, HampelH, MurphyGM, BrachovaL, Yan SDu, WalkerDG, ShenY, RogersJ (2001) Inflammatory repertoire of Alzheimer’s disease and nondemented elderly microglia. Glia35, 72–79.
RauchSM, HuenK, MillerMC, ChaudryH, LauM, SanesJR, JohansonCE, StopaEG, BurgessRW (2011) Changes in brain β-amyloid deposition and aquaporin 4 levels in response to altered agrin expression in mice. J Neuropathol Exp Neurol70, 1124–1137.
67.
ZlokovicBV (2008) The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron57, 178–201.
68.
RauchJN, GestwickiJE (2014) Binding of human nucleotide exchange factors to heat shock protein 70 (Hsp70) generates functionally distinct complexes. J Biol Chem289, 1402–1414.
69.
ErogluB, MoskophidisD, MivechiNF (2010) Loss of Hsp110 leads to age-dependent tau hyperphosphorylation and early accumulation of insoluble amyloid beta. Mol Cell Biol30, 4626–4643.
70.
OstapchenkoVG, BeraldoFH, GuimarãesALS, MishraS, GuzmanM, FanJ, MartinsVR, PradoVF, PradoMAM (2013) Increased prion protein processing and expression of metabotropic glutamate receptor 1 in a mouse model of Alzheimer’s disease. J Neurochem127, 415–425.
71.
BerchtoldNC, CribbsDH, ColemanPD, RogersJ, HeadE, KimR, BeachT, MillerC, TroncosoJ, TrojanowskiJQ, ZielkeHR, CotmanCW (2008) Gene expression changes in the course of normal brain aging are sexually dimorphic. Proc Natl Acad Sci U S A105, 15605–15610.
72.
NebelRA, AggarwalNT, BarnesLL, GallagherA, GoldsteinJM, KantarciK, MallampalliMP, MorminoEC, ScottL, YuWH, MakiPM, MielkeMM (2018) Understanding the impact of sex and gender in Alzheimer’s disease: A call to action. Alzheimers Dement14, 1171–1183.
73.
KrolsM, van IsterdaelG, AsselberghB, KremerA, LippensS, TimmermanV, JanssensS (2016) Mitochondria-associated membranes as hubs for neurodegeneration. Acta Neuropathol131, 505–523.
74.
Area-GomezE, De GroofAJC, BoldoghI, BirdTD, GibsonGE, KoehlerCM, YuWH, DuffKE, YaffeMP, PonLA, SchonEA (2009) Presenilins are enriched in endoplasmic reticulum membranes associated with mitochondria. Am J Pathol175, 1810–1816.
75.
Area-GomezE, SchonEA (2016) Mitochondria-associated ER membranes and Alzheimer disease. Curr Opin Genet Dev38, 90–96.
76.
Area-GomezE, SchonEA (2017) On the pathogenesis of Alzheimer’s disease: The MAM hypothesis. FASEB J31, 864–867.
77.
LiuEY, CaliCP, LeeEB (2017) RNA metabolism in neurodegenerative disease. Dis Model Mech10, 509–518.
78.
BersonA, BarbashS, ShaltielG, GollY, HaninG, GreenbergDS, KetzefM, BeckerAJ, FriedmanA, SoreqH (2012) Cholinergic-associated loss of hnRNP-A/B in Alzheimer’s disease impairs cortical splicing and cognitive function in mice. EMBO Mol Med4, 730–742.
79.
KolisnykB, Al-OnaiziMA, HirataPHF, GuzmanMS, NikolovaS, BarbashS, SoreqH, BarthaR, PradoMAM, PradoVF (2013) Forebrain deletion of the vesicular acetylcholine transporter results in deficits in executive function, metabolic, and RNA splicing abnormalities in the prefrontal cortex. J Neurosci33, 14908–14920.
80.
LauP, BossersK, JankyR, SaltaE, FrigerioCS, BarbashS, RothmanR, SierksmaASR, ThathiahA, GreenbergD, PapadopoulouAS, AchselT, AyoubiT, SoreqH, VerhaagenJ, SwaabDF, AertsS, De StrooperB (2013) Alteration of the microRNA network during the progression of Alzheimer’s disease. EMBO Mol Med5, 1613–1634.
81.
MaozR, GarfinkelBP, SoreqH (2017) Alzheimer’s disease and ncRNAs. Adv Exp Med Biol978, 337–361.
DaulatzaiMA (2015) Olfactory dysfunction: Its early temporal relationship and neural correlates in the pathogenesis of Alzheimer’s disease. J Neural Transm122, 1475–1497.
84.
AnsoleagaB, Garcia-EsparciaP, LlorensF, MorenoJ, AsoE, FerrerI (2013) Dysregulation of brain olfactory and taste receptors in AD, PSP and CJD, and AD-related model. Neuroscience248, 369–382.
85.
ShijoM, HondaH, SuzukiSO, HamasakiH, HokamaM, AbolhassaniN, NakabeppuY, NinomiyaT, KitazonoT, IwakiT (2018) Association of adipocyte enhancer-binding protein 1 with Alzheimer’s disease pathology in human hippocampi. Brain Pathol28, 58–71.
86.
MishraM, PauneskuT, WoloschakGE, SiddiqueT, ZhuL, LinS, GrecoK, BigioEH (2007) Gene expression analysis of frontotemporal lobar degeneration of the motor neuron disease type with ubiquitinated inclusions. Acta Neuropathol114, 81–94.
87.
GrosserC, NeumannL, HorsthemkeB, ZeschnigkM, Van de NesJ (2014) Methylation analysis of SST and SSTR4 promoters in the neocortex of Alzheimer’s disease patients. Neurosci Lett566, 241–246.
88.
GaheteMD, RubioA, Durán-PradoM, AvilaJ, LuqueRM, CastaoJP (2010) Expression of somatostatin, cortistatin, and their receptors, as well as dopamine receptors, but not of neprilysin, are reduced in the temporal lobe of Alzheimer’s disease patients. J Alzheimers Dis20, 465–475.
89.
Saiz-SanchezD, Ubeda-BanonI, De la Rosa-PrietoC, Martinez-MarcosA (2012) Differential expression of interneuron populations and correlation with amyloid-beta deposition in the olfactory cortex of an AbetaPP/PS1 transgenic mouse model of Alzheimer’s disease. J Alzheimers Dis31, 113–129.
90.
HanP, CaselliRJ, BaxterL, SerranoG, YinJ, BeachTG, ReimanEM, ShiJ (2015) Association of pituitary adenylate cyclase-activating polypeptide with cognitive decline in mild cognitive impairment due to Alzheimer disease. JAMA Neurol72, 333–339.
91.
BaiB, HalesCM, ChenP-C, GozalY, DammerEB, FritzJJ, WangX, XiaQ, DuongDM, StreetC, CanteroG, ChengD, JonesDR, WuZ, LiY, DinerI, HeilmanCJ, ReesHD, WuH, LinL, SzulwachKE, GearingM, MufsonEJ, BennettD a, MontineTJ, SeyfriedNT, WingoTS, SunYE, JinP, HanfeltJ, WillcockDM, LeveyA, LahJJ, PengJ (2013) U1 small nuclear ribonucleoprotein complex and RNA splicing alterations in Alzheimer’s disease. Proc Natl Acad Sci U S A110, 16562–16567.
92.
HalesCM, DammerEB, DinerI, YiH, SeyfriedNT, GearingM, GlassJD, MontineTJ, LeveyAI, LahJJ (2014) Aggregates of small nuclear ribonucleic acids (snRNAs) in Alzheimer’s disease. Brain Pathol24, 344–351.
93.
BruinsmaIB, de JagerM, CarranoA, VersleijenAA, VeerhuisR, BoelensW, RozemullerAJM, de WaalRMW, VerbeekMM (2011) Small heat shock proteins induce a cerebral inflammatory reaction. J Neurosci31, 11992–12000.
94.
CarterSF, SchollM, AlmkvistO, WallA, EnglerH, LangstromB, NordbergA (2012) Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: A multitracer PET paradigm combining 11C-Pittsburgh Compound B and 18F-FDG. J Nucl Med53, 37–46.
95.
KanMJ, LeeJE, WilsonJG, EverhartAL, BrownCM, HoofnagleAN, JansenM, VitekMP, GunnMD, ColtonCA (2015) Arginine deprivation and immune suppression in a mouse model of Alzheimer’s disease. J Neurosci35, 5969–5982.
